A comparative study to assess two doses of a novel aldose reductase inhibitor (ARI)/Antioxidant drug candidate Cemtirestat, the current ARI drug Epalrestat, and the antioxidant Stobadine on Fructose- and Streptozotocin-Induced hepatic and pancreatic stress responses in rats. - Dagistanli FK; Ceylan AF; Elmazoglu Z; Efendiyeva N; Sarıbaş SG; Pilafi BK; Stefek M; Ulusu NN; Karasu Ç (Journal of diabetes and metabolic disorders, 2025)